标题
Nanomaterials for T-cell cancer immunotherapy
作者
关键词
-
出版物
Nature Nanotechnology
Volume 16, Issue 1, Pages 25-36
出版商
Springer Science and Business Media LLC
发表日期
2021-01-13
DOI
10.1038/s41565-020-00822-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
- (2020) John D. Martin et al. Nature Reviews Clinical Oncology
- An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
- (2020) Katharina Reinhard et al. SCIENCE
- Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
- (2020) Yukun Huang et al. Nature Communications
- Engineering light-controllable CAR T cells for cancer immunotherapy
- (2020) Ziliang Huang et al. Science Advances
- Chemically Programmable and Switchable CAR‐T Therapy
- (2020) Junpeng Qi et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors.
- (2020) David S. Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
- (2020) Michael Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular backpacks for macrophage immunotherapy
- (2020) C. Wyatt Shields et al. Science Advances
- Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
- (2019) Zongmin Zhao et al. ADVANCED DRUG DELIVERY REVIEWS
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Miniature gold nanorods for photoacoustic molecular imaging in the second near-infrared optical window
- (2019) Yun-Sheng Chen et al. Nature Nanotechnology
- CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
- (2019) Mohamad Hamieh et al. NATURE
- Silencing PD-1 and PD-L1 with nanoparticle-delivered small interfering RNA increases cytotoxicity of tumor-infiltrating lymphocytes
- (2019) Yanheng Wu et al. Nanomedicine
- Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells
- (2019) Qian Chen et al. ADVANCED MATERIALS
- B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
- (2019) Adam D. Cohen et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma.
- (2019) Amir A. Jazaeri et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
- (2019) Noopur Raje et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma
- (2019) Jie Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macroscale biomaterials strategies for local immunomodulation
- (2019) Maxence O. Dellacherie et al. Nature Reviews Materials
- Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
- (2019) Hannah J. Vaughan et al. ADVANCED MATERIALS
- CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
- (2019) Bryan D. Choi et al. NATURE BIOTECHNOLOGY
- Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics
- (2019) Kwang-Soo Kim et al. BIOMATERIALS
- A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
- (2019) Zhichen Sun et al. Nature Communications
- The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells
- (2019) Hannah E. Hughes-Parry et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Nitinol thin films functionalized with CAR-T cells for the treatment of solid tumours
- (2019) Michael E. Coon et al. Nature Biomedical Engineering
- TGF-β Inhibition and Immunotherapy: Checkmate
- (2018) Karuna Ganesh et al. IMMUNITY
- Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy
- (2018) Bijun Zeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
- (2018) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy
- (2018) Wenquan Ou et al. JOURNAL OF CONTROLLED RELEASE
- Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands
- (2018) P. M. Peiris et al. Nanoscale
- Cytokine resurrection: engineered IL-2 ramps up immuno-oncology responses
- (2018) Ken Garber NATURE BIOTECHNOLOGY
- Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
- (2018) Li Tang et al. NATURE BIOTECHNOLOGY
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
- (2018) Margherita Norelli et al. NATURE MEDICINE
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Full control of ligand positioning reveals spatial thresholds for T cell receptor triggering
- (2018) Haogang Cai et al. Nature Nanotechnology
- Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
- (2018) Jonathan T. Sockolosky et al. SCIENCE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Immunoengineering with biomaterials for enhanced cancer immunotherapy
- (2018) Yu-Qing Xie et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma
- (2018) Sandra P. D'Angelo et al. Cancer Discovery
- CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction
- (2018) Natnaree Siriwon et al. Cancer Immunology Research
- Biomaterial-assisted targeted modulation of immune cells in cancer treatment
- (2018) Hua Wang et al. NATURE MATERIALS
- A Status Report on FDA Approval of Medical Devices Containing Nanostructured Materials
- (2018) A-Andrew D. Jones et al. TRENDS IN BIOTECHNOLOGY
- Emerging Cellular Therapies for Cancer
- (2018) Sonia Guedan et al. Annual Review of Immunology
- FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- (2018) Maura C. O’Leary et al. CLINICAL CANCER RESEARCH
- A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus-associated epithelial cancers
- (2018) Sanja Stevanovic et al. CLINICAL CANCER RESEARCH
- FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
- (2018) Najat Bouchkouj et al. CLINICAL CANCER RESEARCH
- Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity
- (2018) Qinqin Cheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- Making CAR T Cells a Solid Option for Solid Tumors
- (2018) Andrea Schmidts et al. Frontiers in Immunology
- The potential and promise of IL-15 in immuno-oncogenic therapies
- (2017) Tanya O. Robinson et al. IMMUNOLOGY LETTERS
- Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
- (2017) Tyrel T. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers
- (2017) Elizabeth L. Siegler et al. MOLECULAR THERAPY
- Noninvasive Targeted Transcranial Neuromodulation via Focused Ultrasound Gated Drug Release from Nanoemulsions
- (2017) Raag D. Airan et al. NANO LETTERS
- In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
- (2017) Tyrel T. Smith et al. Nature Nanotechnology
- Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy
- (2017) Hengfeng Yuan et al. Nature Nanotechnology
- The evolving landscape of drug products containing nanomaterials in the United States
- (2017) Sheetal R. D'Mello et al. Nature Nanotechnology
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Boosting the down-shifting luminescence of rare-earth nanocrystals for biological imaging beyond 1500 nm
- (2017) Yeteng Zhong et al. Nature Communications
- T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
- (2017) Daniela Schmid et al. Nature Communications
- “Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy
- (2016) Jessica A. Kemp et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
- (2016) J. M. Pitt et al. ANNALS OF ONCOLOGY
- Effect of surface properties on liposomal siRNA delivery
- (2016) Yuqiong Xia et al. BIOMATERIALS
- Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
- (2016) Nazila Kamaly et al. CHEMICAL REVIEWS
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting
- (2016) Clare Y. Slaney et al. CLINICAL CANCER RESEARCH
- Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
- (2016) Eugene A Zhukovsky et al. CURRENT OPINION IN IMMUNOLOGY
- Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study
- (2016) Maria-Elisabeth Goebeler et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin
- (2016) Grant H. Petersen et al. JOURNAL OF CONTROLLED RELEASE
- Role of nanoparticle size, shape and surface chemistry in oral drug delivery
- (2016) Amrita Banerjee et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- (2016) Daniel Bobo et al. PHARMACEUTICAL RESEARCH
- Bioresponsive materials
- (2016) Yue Lu et al. Nature Reviews Materials
- PEGylation in anti-cancer therapy: An overview
- (2016) Prajna Mishra et al. Asian Journal of Pharmaceutical Sciences
- Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging
- (2015) Rinat Meir et al. ACS Nano
- Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells
- (2015) Michael D. McHugh et al. BIOMATERIALS
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- Remote control of therapeutic T cells through a small molecule-gated chimeric receptor
- (2015) C.-Y. Wu et al. SCIENCE
- Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
- (2015) Bonnie Huang et al. Science Translational Medicine
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- PLGA-nanoparticle mediated delivery of anti-OX40 monoclonal antibody enhances anti-tumor cytotoxic T cell responses
- (2014) Mingshui Chen et al. CELLULAR IMMUNOLOGY
- The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response to Treatment in Patients with Metastatic Renal Cell Carcinoma
- (2014) David F. McDermott et al. CLINICAL CANCER RESEARCH
- Bispecific T-cell engagers for cancer immunotherapy
- (2014) Amelia M Huehls et al. IMMUNOLOGY AND CELL BIOLOGY
- Cancer active targeting by nanoparticles: a comprehensive review of literature
- (2014) Remon Bazak et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Biopolymer implants enhance the efficacy of adoptive T-cell therapy
- (2014) Sirkka B Stephan et al. NATURE BIOTECHNOLOGY
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Mixed-Charge Nanoparticles for Long Circulation, Low Reticuloendothelial System Clearance, and High Tumor Accumulation
- (2014) Xiangsheng Liu et al. Advanced Healthcare Materials
- Chronic Inflammation and Cytokines in the Tumor Microenvironment
- (2014) Glauben Landskron et al. Journal of Immunology Research
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
- (2013) Yiran Zheng et al. JOURNAL OF CONTROLLED RELEASE
- Stimuli-responsive nanocarriers for drug delivery
- (2013) Simona Mura et al. NATURE MATERIALS
- Physicochemical Properties Determine Nanomaterial Cellular Uptake, Transport, and Fate
- (2012) Motao Zhu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
- (2012) Jason Park et al. NATURE MATERIALS
- Physicochemical Characteristics of Nanoparticles Affect Circulation, Biodistribution, Cellular Internalization, and Trafficking
- (2012) Xiaopin Duan et al. Small
- CAR–T cells and solid tumors: tuning T cells to challenge an inveterate foe
- (2012) David E. Gilham et al. TRENDS IN MOLECULAR MEDICINE
- Effective Melanoma Immunotherapy with Interleukin-2 Delivered by a Novel Polymeric Nanoparticle
- (2011) H. Yao et al. MOLECULAR CANCER THERAPEUTICS
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection
- (2010) Jens Lipka et al. BIOMATERIALS
- Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
- (2010) Chrystal U. Louis et al. JOURNAL OF IMMUNOTHERAPY
- The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging
- (2010) Zhanwen Xing et al. NANOTECHNOLOGY
- Safety and immunologic effects of IL-15 administration in nonhuman primates
- (2009) C. Berger et al. BLOOD
- Bispecific T-Cell Engaging Antibodies for Cancer Therapy
- (2009) P. A. Baeuerle et al. CANCER RESEARCH
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now